Advanced search
Publication Cover
Scandinavian Journal of Primary Health Care Volume 38, 2020 - Issue 3
Submit an article Journal homepage
1,001
Views
2
CrossRef citations to date
0
Altmetric
Editorials

A Nordic initiative for a more personal and accurate diagnostic pathway for prostate cancer

Svein R. Kjosavika The General Practice and Care Coordination Research Group, Stavanger University Hospital, Stavanger, Norway;b Faculty of Health Sciences, University of Stavanger, Stavanger, NorwayCorrespondence[email protected]
,
Karina Dalsgaard Sørensenc Department of Clinical Medicine, Aarhus University, Aarhus, Denmark;d Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
,
Kristina Hotakainene Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland;f Mehiläinen Oy Laboratory, Helsinki, Finland
&
Henrik Grönbergg Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;h Department of Oncology, Capio S:t Görans Hospital, Stockholm, Sweden
Pages 249-250 | Accepted 06 Jul 2020, Published online: 14 Aug 2020

References

  • NORCAN. Comparable cancer statistics for Denmark, Finland, Iceland, Norway, Sweden, the Faroe Islands, and Greenland: ANCR, association of the Nordic cancer registries; 2020. [cited 2020 June 5]. Available from: https://nordcan.iarc.fr/en
  • Beauchamp TL, Childress JF. Principles of biomedical ethics. New York (NY): Oxford University Press; 2013.
  • Opdal PO, Meland E, Hjorleifsson S. Dilemmas of medical overuse in general practice - A focus group study. Scand J Prim Health Care. 2019;37(1):135–140.
  • Solvang M, Elnegaard S, Jarbol DE. Urological symptoms among 23,240 men in the general Danish population - concerns about symptoms, their persistence and influence on primary care contacts. Scand J Prim Health Care. 2018;36(3):227–236.
  • Chandra Engel J, Palsdottir T, Aly M, et al. Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50–69 years with PSA >/=3 ng/ml. Scand J Urol. 2020;54(1):1–6.
  • Bergman M, Hjalm Ericsson M, Jaderling F, et al. [Improved prostate cancer diagnostics with a struc-tured pathway including the Stockholm3 test and MRI–targeted biopsies - experiences from Capio S:t Göran Prostate Cancer Center]. Läkartidningen. 2018;115:FCDT.
  • Gronberg H, Adolfsson J, Aly M, et al. Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study. Lancet Oncol. 2015;16(16):1667–1676.
  • Viste E, Vinje CA, Lid TG, et al. Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system - the Stavanger experience. Scand J Prim Health Care. 2020;38(3). This issue.
  • Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017;317(24):2532–2542.
  • Filson CP, Natarajan S, Margolis DJ, et al. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies. Cancer. 2016;122(6):884–892.
  • Strom P, Kartasalo K, Olsson H, et al. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol. 2020;21(2):222–232.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.